The Indian drug regulator will on Friday approve the emergency use developed by AstraZeneca and Oxford University.
Covid 19 Vaccine India Update: The Indian drug regulator will on Friday approve the emergency use developed by AstraZeneca and Oxford University. This has been said in the Reuters report. With this, according to the news agency PTI, the CDSCO expert panel is going to approve the Oxford COVID-19 vaccine Covishield in India. It will become the first vaccine to be approved in India.
This decision will bring the vaccine to India, the world’s second-most populous country. India comes second in the world in terms of the number of corona cases.
Britain and Argentina had previously approved
Britain and Argentina have already approved the vaccine for emergency use. Experts of India’s Central Drugs Standard Control Organization (CDSCO) are meeting for the second time this week. They can also approve a vaccine developed in the country for India Biotech.
According to a report by Royals, sources said that both AstraZeneca and Bharat Biotech vaccines could be approved today. All preparations have been made keeping in mind the present date. The report said that other sources were less certain about Bharat Biotech.
The stock of over 50 million doses
This meeting of the group is taking place before the nationwide trial run for vaccine delivery in the country. Stocks of more than 50 million doses of the AstraZeneca vaccine have been maintained by its local manufacturer Serum Institute of India (SII). And the start of moving the shot from cold storage to the states in India can be started from Saturday. SII said in the email that she would wait for the final approval before reacting.
The Indian government said on Wednesday that Pfizer Inc has asked for some more time to approve its vaccine. He has developed the vaccine with BioNTech in Germany.